A buyer bought in pre CSPA 250,000 shares at .44. That’s more volume than what was traded before 4pm. Had his order at .43 and moved it up
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come